An improved fetal hemoglobin for genetic correction of sickle cell disease

摘要

Methods and compositions disclosed herein generally relates to methods of determining minimum hematopoietic stem cell (HSC) chimerism and gene dosage for correction of a hematopoietic disease; in particular, in